Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis
Fotocitizen / Pixabay

Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: From Afraid to Advocate: How Natalie Found Her Power After a Friedreich’s Ataxia Diagnosis
Merkel Cell Carcinoma Has Taken the Life of Jimmy Buffett After Fending Off Cancer for Four Years
source: shutterstock.com

Merkel Cell Carcinoma Has Taken the Life of Jimmy Buffett After Fending Off Cancer for Four Years

  Jimmy Buffett survived a 1994 plane crash that was the inspiration for his song “Live Like It’s Your Last Day." According to an obituary on his website, Jimmy, 76,…

Continue Reading Merkel Cell Carcinoma Has Taken the Life of Jimmy Buffett After Fending Off Cancer for Four Years
Rare Community Profiles: Understanding MAC Lung Disease, Bronchiectasis, and PAH: A Discussion with Dr. Martina Flammer
source: pixabay.com

Rare Community Profiles: Understanding MAC Lung Disease, Bronchiectasis, and PAH: A Discussion with Dr. Martina Flammer

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Understanding MAC Lung Disease, Bronchiectasis, and PAH: A Discussion with Dr. Martina Flammer
Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus
source: shutterstock.com

Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus

The Phase 3 LITESPARK-005 trial sought to understand whether Welireg (belzutifan) was effective in treating advanced renal cell carcinoma (RCC) when compared to other treatments, such as everolimus. According to…

Continue Reading Belzutifan Improves Progression-Free Survival for Renal Cell Carcinoma Over Everolimus
September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 17-23 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, a Patient Worthy partner organization, the goal of this campaign is to help…

Continue Reading September 17-23 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
The Assistance Fund Offers New Financial Assistance Program for People with Idiopathic Hypersomnia (IH)
HeatherPaque / Pixabay

The Assistance Fund Offers New Financial Assistance Program for People with Idiopathic Hypersomnia (IH)

As many people within the rare disease community know, a rare disease diagnosis can come with a significant financial burden. Additionally, the costs, treatments, equipment, and other needs are not…

Continue Reading The Assistance Fund Offers New Financial Assistance Program for People with Idiopathic Hypersomnia (IH)
Orphan Drug Designation Granted to Three Active Moieties of INT230-6 for Soft Tissue Sarcoma (STS)
Source: Pixabay.com

Orphan Drug Designation Granted to Three Active Moieties of INT230-6 for Soft Tissue Sarcoma (STS)

INT230-6, developed by clinical-stage biotechnology company Intensity Therapeutics (“Intensity”), is an investigational therapy comprising three moieties: cisplatin, SHAO-FA (a penetration enhancing molecule), and vinblastine sulfate. A moiety, in this sense,…

Continue Reading Orphan Drug Designation Granted to Three Active Moieties of INT230-6 for Soft Tissue Sarcoma (STS)
Patients and Doctors Are Pressuring Health Insurance Companies Online in Order to Receive Proper Treatment
source: pixabay.com

Patients and Doctors Are Pressuring Health Insurance Companies Online in Order to Receive Proper Treatment

  Social media has become a vehicle for customer complaints and the companies are listening. Estimates are that almost two-thirds of dissatisfied customers have received a response to their online…

Continue Reading Patients and Doctors Are Pressuring Health Insurance Companies Online in Order to Receive Proper Treatment

Glofitamab with Obinutuzumab Shows Promise in Heavily Pretreated Richter Syndrome

Also known as Richter’s Transformation, Richter syndrome is a rare and aggressive complication of chronic lymphocytic leukemia (CLL). When someone develops Richter syndrome, their CLL can transform into another rare…

Continue Reading Glofitamab with Obinutuzumab Shows Promise in Heavily Pretreated Richter Syndrome

Lila’s Journey: Staying Positive While Living With Pediatric Low-Grade Glioma (pLGG)

Acknowledgment: This story is sponsored by Day One Biopharmaceuticals and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant,…

Continue Reading Lila’s Journey: Staying Positive While Living With Pediatric Low-Grade Glioma (pLGG)